| Business Name: |
Dermatrends Inc |
| Contact Person: |
Ted Sthwarzrock |
| Address: |
10130 Sorrento Valley Road A, San Diego, California 92121 |
| Phone Number: |
(858) 909-0662 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Founding Year: |
2003 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B (Business to Business) |
| Business Category: |
Commercial Biotechnical Research |
| SIC Code: |
8731 |
| NAICS Code: |
541711 |
| Share This Business: |
|
| Related Businesses: |
Genestitute - San Diego, CA 92121
Abide Therapeutics - San Diego, CA 92121
Miltenyi Biotec Inc - San Diego, CA 92121
Ignyta - San Diego, CA 92121
Center For Aquaculture Tech - San Diego, CA 92121
Aires Pharmaceuticals Inc - San Diego, CA 92121
Oranox - San Diego, CA 92121
Rd Biosciences Inc - San Diego, CA 92121
Zenobia Therapeutics - San Diego, CA 92121
Arytha Biosciences LLC - San Diego, CA 92121
Abwiz Bio Inc - San Diego, CA 92121
Advantar Laboratories Inc - San Diego, CA 92121
Proacta Inc - San Diego, CA 92121
Anaptysbio Inc - San Diego, CA 92121
Nod Pharmaceuticals Inc - San Diego, CA 92121
Kinome Scan - San Diego, CA 92121
One World Lab Inc - San Diego, CA 92121
Motivatrx LLC - San Diego, CA 92121
Mapp Biopharmaceutical Inc - San Diego, CA 92121
Fate Therapeutics Inc - San Diego, CA 92121
|
The company Dermatrends Inc provides B2B services in the form of Commercial Biotechnical Research from its single location in California.
1 to 4 employees work for Dermatrends Inc, and the business now earns $500.000 to $999.999 per annum.
Dermatrends Inc was launched in 2003 and is classified under SIC code and category 8731 , and NAICS number and grouping 541711 .
To contact Dermatrends Inc, please call Ted Sthwarzrock with the phone number (858) 909-0662 or visit its single location at 10130 Sorrento Valley Road A in San Diego, California 92121.
The location of the single location can also be found using the coordinates .
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.